Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site. - Wikidata - awgldk - TriplyDB

Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.

Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.

http://www.wikidata.org/entity/Q38596477

about

Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.Structural basis for engagement by complement factor H of C3b on a self surface Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement Structure of the N-terminal region of complement factor H and conformational implications of disease-linked sequence variations Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism Properdin: a tightly regulated critical inflammatory modulator Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.Leptospira interrogans endostatin-like outer membrane proteins bind host fibronectin, laminin and regulators of complement Complement in glomerular injury.What's new in haemolytic uraemic syndrome?Advances in understanding of pathogenesis of aHUS and HELLP.Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.Genetics and complement in atypical HUS.Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities.Red blood cell Thomsen-Friedenreich antigen expression and galectin-3 plasma concentrations in Streptococcus pneumoniae-associated hemolytic uremic syndrome and hemolytic anemia.Self-nonself discrimination by the complement system.HUS and atypical HUS.Staphylococcus aureus SdrE captures complement factor H's C-terminus via a novel 'close, dock, lock and latch' mechanism for complement evasion Review: Complement and its regulatory proteins in kidney diseases.Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage.Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi.Complement control protein factor H: the good, the bad, and the inadequate.Microbes bind complement inhibitor factor H via a common site Molecular characterization of the interaction between sialylated Neisseria gonorrhoeae and factor H.Factor H mediated cell surface protection from complement is critical for the survival of PNH erythrocytes.Survey of the year 2005 commercial optical biosensor literature.Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.Progress in defining the molecular biology of age related macular degeneration.Lyme borreliosis spirochete Erp proteins, their known host ligands, and potential roles in mammalian infection.Translational mini-review series on complement factor H: structural and functional correlations for factor H.Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium.The C-terminus of complement factor H is essential for host cell protection.Factor H and neisserial pathogenesis.A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.Dynamic control of the complement system by modulated expression of regulatory proteins.Factor h: a complement regulator in health and disease, and a mediator of cellular interactions.

P2860

Q24543850-53F8A657-2BC7-410D-95A8-75B50D803419 Q24604385-C70388DC-80D5-45C9-A073-AFBEB4AE117F Q24619612-3FFDA639-DA64-4434-B6C4-2E4370845209 Q24648540-6BBD8D3B-1B88-4577-AADF-77855B1ADCF9 Q24685473-845AC427-4679-4804-B3C9-153B44E6FFD7 Q27644071-129C07EE-14C1-4A7E-BDA7-2D7049ADD530 Q28069187-1F7AC9AB-C45C-4C88-B51E-D764E282599E Q28301693-2E2B9516-2B8C-4BBD-8DB7-2B1708C16006 Q30377280-153A2055-ED29-4EE3-8D37-6FA725E2E790 Q33305446-1F4E478B-988E-4900-82AB-AA9B039CD5A5 Q33376840-53FCC10C-1D21-435F-8CA1-F415C2B473F8 Q33380073-93CD772C-D03C-4989-9111-A5F649E50019 Q33380684-C6356543-8B40-41C4-B064-B71F060EF9A4 Q33384039-15C9087C-9324-490C-9554-71C5EEE462B0 Q33385035-F7CA4E68-0A96-4F04-8A4C-B493E24C3BC0 Q33389945-CB41A65D-4211-48A6-9E9B-111D63C75BBF Q33393852-72F4345F-6996-4864-B024-AFF7DA810575 Q33419595-F48B73E9-2E91-4A41-A20E-ADD6CF1E43C2 Q33433754-03A52E7B-C094-4DF7-8B87-E8BE94F20DC8 Q33441069-ABEE315E-DBEA-4D28-BAA1-F64F84821FC2 Q33634976-1545377F-A450-4685-9906-4084F359682D Q33647738-241C9A76-EBA2-4E87-A97A-6B4BE4BFEA37 Q33668640-6591FA40-2990-4B0B-8C6D-370744CE6C0F Q33680856-EC186AC6-05D6-4EB0-9623-00F247460D4D Q33728030-29554036-5737-4D11-A99B-BF7A08DC6DD9 Q34067107-0119AD1B-50E8-4F59-9755-3E01FF6903BC Q34699715-4D20F830-D5D3-4FF3-A439-33D530645CDF Q35063071-FF08BB22-D055-43C5-AB33-F9A20E2C2851 Q35990700-85D4B04B-6B49-45F2-A9B5-7CC7EEB5BB9D Q36662814-C3569374-0E02-4832-A3BA-EC081271A4AB Q36778860-66DBE14A-7E94-4437-9524-1ED38CC6D180 Q36894556-D6AD4D96-6382-4F55-8331-B5D7A4C54EF3 Q36999798-49D7EF6A-DC54-4A3A-B750-4C00735EBBF7 Q37032788-6E592387-1753-4327-BE18-1D4FB2829FBA Q37077537-22F707F7-4EF6-4831-8DB6-AA872CB5550B Q37238656-1B3E18E4-02C7-4E81-9C32-67427DFE159B Q37401428-427C3D99-3E33-465F-8FE1-7D3965870108 Q37434667-746BCADE-AAF3-427C-BAF0-51E81DF7E1BB Q37797869-B5A3469C-215F-44F9-A135-B6ABFE5BDC40 Q38223669-C786F9E9-94BC-4348-A730-FA7D9545DC57

P2860

Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.

http://www.wikidata.org/entity/Q38596477

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Binding of complement factor H ...... lycosaminoglycan binding site.

@en

type

label

Binding of complement factor H ...... lycosaminoglycan binding site.

@en

prefLabel

Binding of complement factor H ...... lycosaminoglycan binding site.

@en

P1433

Q38596477-E3886668-D7FD-4578-B639-ADAC282912B8

P1476

Q38596477-A6BFD55B-71A7-40C3-927A-C0703E176B9A

P2093

Q38596477-3079EFE8-EC88-488A-A737-2B820862AC25

Q38596477-330D8D2B-B282-46E3-A98A-B4713668E84D

Q38596477-6002AF7C-3151-4076-9B11-6D33D8648EE9

Q38596477-893D378A-E72B-47E9-A48F-0DAE7D7FCE08

Q38596477-916845FA-01D7-4B33-B35F-FAF27684E644

Q38596477-A0FC6078-A40E-407A-9782-82DA11DDBDC3

Q38596477-BE3FB88E-B410-4F99-B754-4560BCB6CBFD

Q38596477-D7F60039-E2D7-4E15-9C48-C4A07F43B11C

Q38596477-DF5C0AA0-908B-41A3-B7AF-136024AE5C6A

P2860

Q38596477-09EC73B1-75AF-4867-A3FE-5C0F762F77D2

Q38596477-12D71916-8332-4A14-B200-44EC195E078D

Q38596477-162FE944-21F2-4E72-8123-63136255B7FE

Q38596477-168C9411-4142-44D6-A896-0DD40C421F91

Q38596477-1B15E0E5-4542-4CA4-999B-F28F56640585

Q38596477-1C8C2FE9-A546-4D70-B6C2-03017A37692E

Q38596477-22851FA9-3E42-47C4-974C-1CB26B7B2A18

Q38596477-2AB4E6BD-4100-451E-892A-9A2AE2A36F93

Q38596477-2FD8CB95-9900-490D-99AC-2667FA56DDC9

Q38596477-365EDFDC-3BF3-4E7C-980C-588CB7044916

P304

Q38596477-0D070989-6A37-41DC-B733-4823DFF3D965

P31

Q38596477-24929DC2-9403-4E74-B5AB-828E96D53703

P356

Q38596477-99E3391D-CCAD-40A3-99C3-5BE6CE3B18B3

P407

Q38596477-48F9BB04-3C6A-4393-ABE0-1744FE50BB0C

P433

Q38596477-6167A2B5-7556-46FA-8E83-5D6BB78AA209

P478

Q38596477-D3817BC5-E1D8-4A34-896E-8ECD9098121A

P50

Q38596477-64B1F8C8-E3EE-475E-BAC0-BD8017842ECD

Q38596477-98E8D7A3-3E09-49BD-B8BF-B1E1C7B33743

Q38596477-E1222B24-7E61-4D6F-8C2B-8611142D79F6

P577

Q38596477-49663270-9387-4189-B745-764B590A5583

P5875

Q38596477-F17F499D-19CF-4DAC-9FA7-72FF3689CBB9

P698

Q38596477-27D07A67-BE27-4848-9997-B768158084E7

P921

Q38596477-9FCE0C64-6525-4D98-BAAD-34EEB26660FC

P932

Q38596477-A2409CFF-33B2-43B5-A2F4-9707AD0F2BDB

P356

S0002-9440(10)61205-9

P1433

The American Journal of Pathology

P1476

Binding of complement factor H ...... lycosaminoglycan binding site.

@en

P2093

David L Gordon

http://www.w3.org/2001/XMLSchema#string

Harald Seeberger

http://www.w3.org/2001/XMLSchema#string

Jens Hellwage

http://www.w3.org/2001/XMLSchema#string

Marina Noris

http://www.w3.org/2001/XMLSchema#string

Mihály Jòzsi

http://www.w3.org/2001/XMLSchema#string

Rebecca Ormsby

http://www.w3.org/2001/XMLSchema#string

Seppo Meri

http://www.w3.org/2001/XMLSchema#string

T Sakari Jokiranta

http://www.w3.org/2001/XMLSchema#string

Zhu-Zhu Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Control of the amplification convertase of complement by the plasma protein beta1H

Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution

Complement C3b interactions studied with surface plasmon resonance technique

Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura

The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.

Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition

Familial hemolytic uremic syndrome associated with complement factor H deficiency.

Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome

Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.

Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries

P304

1173-1181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)61205-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Remuzzi

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7571599

http://www.w3.org/2001/XMLSchema#string

P698

16192651

http://www.w3.org/2001/XMLSchema#string

P921

P932

1603661

http://www.w3.org/2001/XMLSchema#string